An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha
- Status
- COMPLETED
- Phase
- PHASE2
An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
- Status
- COMPLETED
- Phase
- PHASE3
An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen
- Status
- COMPLETED
- Phase
- PHASE4
Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)
- Status
- COMPLETED
- Phase
- PHASE4
Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Imatinib in Chordoma
- Status
- COMPLETED
- Phase
- PHASE2